Get started
Author

Letizia Marinaro

Observed names: L Marinaro, L. Marinaro, Letizia MARINARO, Letizia Marinaro 15, MARINARO, Letizia, Marinaro L, Marinaro L.
ORCID: 0000-0002-0896-1469
Observed ORCID: 0000-0002-0896-1469
OpenAlex ID: A5041620539
Cerebrospinal Fluid Inhibitory Quotients of Antiretroviral Drugs in HIV-Infected Patients Are Associated With Compartmental Viral Control
2014 · Andrea Calcagno, Marco Simiele, et al. · Clinical Infectious Diseases · 59
PDF
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1–4 in Italy
2018 · Ada Bertoli, Maria Chiara Sorbo, et al. · Scientific Reports · 50
PDF
Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogenetics
2012 · Andrea Calcagno, Aylin Yilmaz, et al. · AIDS · 41
Clinical pharmacology of tenofovir clearance: a pharmacokinetic/pharmacogenetic study on plasma and urines
2015 · A Calcagno, J Cusato, et al. · The Pharmacogenomics Journal · 35
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?
2017 · Velia Chiara Di Maio, Valeria Cento, et al. · Journal of Hepatology · 32
PDF
Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection
2020 · Mattia Trunfio, Elena Salvador, et al. · Thrombosis Research · 27
PDF
Efavirenz pharmacogenetics in a cohort of Italian patients
2015 · Jessica Cusato, Cristina Tomasello, et al. · International Journal of Antimicrobial Agents · 26
HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated Patients
2015 · Andrea Calcagno, Ilaria Motta, et al. · AIDS Research and Human Retroviruses · 24
Anaphylaxis due to fish hypersensitivity in an exclusively breastfed infant
2006 · Giovanna Monti, Letizia Marinaro, et al. · Acta Paediatrica · 21
Multiple Bone Fractures in an 8-Year-Old Child with Cow’s Milk Allergy and Inappropriate Calcium Supplementation
2007 · Giovanna Monti, Valentina Libanore, et al. · Annals of Nutrition and Metabolism · 19
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study)
2015 · S. Bonora, S. Rusconi, et al. · Journal of Antimicrobial Chemotherapy · 17
PDF
Therapeutic drug monitoring of boosted PIs in HIV-positive patients: undetectable plasma concentrations and risk of virological failure
2017 · A. Calcagno, N. Pagani, et al. · Journal of Antimicrobial Chemotherapy · 15
PDF
Tenofovir clearance is reduced in HIV-positive patients with subclinical tubular impairment
2015 · Andrea Calcagno, Jessica Cusato, et al. · AIDS · 13
PDF
Transplacental passage of etravirine and maraviroc in a multidrug-experienced HIV-infected woman failing on darunavir-based HAART in late pregnancy
2013 · A. Calcagno, L. Trentini, et al. · Journal of Antimicrobial Chemotherapy · 13
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study
2025 · Luca Rinaldi, Mauro Viganò, et al. · Viruses · 12
PDF
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants
2023 · Jessica Cusato, Valeria Avataneo, et al. · Diagnostics · 9
PDF
The Outcome of HIV-Positive Late Presenters According to Detectable CMV DNA and Anti-CMV Treatment
2017 · Paolo Bigliano, Andrea Calcagno, et al. · Antiviral Therapy · 9
PDF
Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics
2015 · Andrea Calcagno, Chiara Montrucchio, et al. · Current HIV Research · 9
Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients
2014 · A. Calcagno, L. Marinaro, et al. · Antiviral Research · 9
PDF
Tenofovir disoproxil fumarate discontinuation for renal outcomes: any room for treatment personalization?
2018 · A. Calcagno, M. Fiumanò, et al. · The Pharmacogenomics Journal · 8
Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosis
2016 · Marco Merli, Laura Galli, et al. · Journal of Antimicrobial Chemotherapy · 8
PDF
Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients
2019 · Jessica Cusato, Andrea Calcagno, et al. · The Pharmacogenomics Journal · 7
PDF
Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting
2016 · Letizia Marinaro, Andrea Calcagno, et al. · Journal of Clinical Virology · 7
Efficacy, Tolerability and Virological Consequences of Long-Term Use of Unboosted Atazanavir Plus 2 NRTIs in HIV-Infected Patients
2014 · S. Bonora, A. Calcagno, et al. · Current HIV Research · 7
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm
2025 · Gian Paolo Caviglia, Eleonora Dileo, et al. · Liver International · 5
PDF
Works count: 74
Citation count: 508
H-index: 13
I10-index: 15
Year
Topic
Type